Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Multi-Site STARgraft (10401) Trial

NCT: NCT07557862 · NOT_YET_RECRUITING

NCT IDNCT07557862
StatusNOT_YET_RECRUITING
Start Date2026-07
Completion2029-06

Brief Summary

This is a multi-site, single-blind with parallel group, randomized controlled trial of Healionics STARgraft (10401) vascular graft for hemodialysis access compared with a market-leading commercially available ePTFE vascular graft (Gore Propaten Vascular Graft).

Frequently Asked Questions

What is Multi-Site STARgraft (10401) Trial?

Multi-Site STARgraft (10401) Trial is a clinical trial registered under NCT07557862. Current status: NOT_YET_RECRUITING.

What is the status of NCT07557862?

The current status of NCT07557862 (Multi-Site STARgraft (10401) Trial) is: NOT_YET_RECRUITING.

When did Multi-Site STARgraft (10401) Trial start?

Multi-Site STARgraft (10401) Trial started on 2026-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑